ApconiX Welcomes Katie Cox to The Team

Katie joins ApconiX as a placement student for the month of July.  Katie, a third-year student from Sheffield University studying Biomedical Sciences hopes to carry on with her studies and complete a master’s degree at Sheffield after graduation.

Eager to gain experience of a real-world laboratory, Katie took her tutor’s advice and applied.  Dr Stephen Brown whose research interests include functional genomics, siRNA genome screens, drug screening, cell models of human disease knew it would be an excellent opportunity to turn the theory of ion channels into practice.

Katie will be shadowing Dr Michael Morton and Dr Karen Jones as they carry out ion channel screening and assay development to support their valued customers in making better decisions.

Mike added “We’re very happy to welcome placements students.  We honestly believe it is incumbent on us to help train the scientists of the future”.

By |2018-07-11T09:42:42+00:00July 5th, 2018|Careers|Comments Off on ApconiX Welcomes Katie Cox to The Team

About the Author:

Dr Michael Morton, PhD, Director and Cofounder, ApconiX, UK, an integrated toxicology and ion channel company that brings together a team of world-renowned nonclinical safety experts with over 400 years of drug discovery and development experience. Mike graduated from the University of Wolverhampton with a degree in Biomedical Sciences and then aspiration to work in hospital pathology. Having finished his Sandwich placement in Clinical Biochemistry at Sandwell Hospital and Mike subsequently gained a MSc in Clinical Biochemistry from the University of Manchester and carried out research into porphyrin metabolism. Moving to the University of Leeds, Mike completed his PhD in Pharmacology at researching adenosine receptor expression in the rat kidney . Mike was introduced to ion channels as a Post-Doc at Leeds and Yale University, patching with the likes of Fred Sigworth and Steve Hebert, then joined the Global Ion Channel Initiative at AstraZeneca. Mike worked at AstraZeneca for eight years before founding ApconiX with Professor Ruth Roberts and Dr Richard Knight. Mike has a serious passion for ion channels. And he’s very good at them . He is a serious scientist (with a serious sense of humour) who wants to make sure that every customer understands the consequences of the results he obtains and works with his colleagues to ensure a better decision is made on drug safety.